INVA - Innoviva Therapeutics Quarterly EPS earnings growth

Official company branding of inva.com (INVA)

Innoviva, Inc. generates revenue from multi-million dollar licensing payments derived from global sales of respiratory medications. The quarterly EPS trend clearly demonstrates earnings per share, where the level of -194.30 represents the current value. The holding company is implementing ESG principles by managing the environmental risks of its subsidiaries. Stable patent payments ensure exceptional business resilience, completely eliminating dependence on price wars within the sector.

Innoviva (INVA) Earnings per share growth in annualized terms for the last twelve months: for the period 07/04/2022 - 11/16/2026

Comprehensive metric breakdowns and analytics for Innoviva, Inc. (INVA)

- share price and consensus valuation forecast:
Analysis of all company metrics:Innoviva, Inc.
Flagship merchandise of Innoviva Therapeutics

The resilience of Innoviva, Inc. (INVA) depends on the steady inflow of royalties from global partners. By analyzing the growth rate of quarterly earnings per share, an investor can see the market's reaction to geopolitical risks associated with drug distribution. This metric calculates the percentage change in net income for the period relative to the previous year. Positive momentum confirms the effectiveness of patent protection. These data allow for an adjustment of the company's fair asset value.

Key competitors

IEP: Quarterly EPS earnings growth|Hannon Armstrong Capital - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Central Securities Corp|CNNE: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Cabot Credit Details (ECPG)|PRAA - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth BGH (Barings Global Short)|Acacia Corp - Year-over-year earnings per share growth for the last twelve months|nb.com - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months cloughglobal.com GLO|Nuveen Real Estate Fund (JRS) - Year-over-year earnings per share growth for the last twelve months|HGLB - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Roma Green Finance Limited|Year-over-year earnings per share growth for the last 12 months OCCI (OFS Credit)|Quarterly EPS earnings growth BANX|Year-over-year earnings per share growth for the last twelve months EDF (Virtus Stone Harbor Emerging Markets Income Fund)|Quarterly EPS earnings growth GNT (gabelli.com)|DOMH: Year-over-year earnings per share growth for the last 12 months|hginc.com - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months RFL|Eagle Capital Growth Fund Inc (GRF) - Year-over-year earnings per share growth for the last twelve months|AAMC: Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mill City Ventures|Earnings per share growth in annualized terms for the last twelve months Tortoise Pipeline & Energy Fund TTP